This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Millonig, J. H. Articles by Tilghman, S. M. Search for Related Content PubMed PubMed Citation Articles by Millonig, J. H. Articles by Tilghman, S. M.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 07 1995, 3848-3856, Vol 15, No. 7
Copyright © 1995, American Society for Microbiology

Molecular analysis of the distal enhancer of the mouse alpha- fetoprotein gene

JH Millonig, JA Emerson, JM Levorse and SM Tilghman
Howard Hughes Medical Institute, Princeton University, New Jersey 08544, USA.

The mouse alpha-fetoprotein (AFP) gene is transcribed at high levels in the visceral endoderm of the yolk sac and fetal liver and at much lower rates in the endoderm of the fetal gut. Expression of the gene in vivo requires the presence of at least one of three enhancers which lie in its 5' flanking region. In this report, we establish that the most distal AFP enhancer directed consistent expression of a linked AFP minigene in all three endodermal tissues in transgenic mice. The enhancer is composed of three domains, each of which is essential for full enhancer function by transient transfection assays. DNase I footprinting identified three regions of the enhancer which are protected by human hepatoma nuclear extracts, one of which corresponded to a consensus site for HNF-3 binding. Site-directed mutations in this site caused a 10-fold reduction in enhancer function by transient transfection. In transgenic mice, however, the mutation resulted in sporadic expression of the transgene, dependent on the site of integration. A similar acquisition of position-dependent sporadic expression of the transgene was observed with a mutation in a second protein binding site, despite the fact that this mutation had very little effect on enhancer function as assessed by transient transfection. These studies underscore the value of examining the functions of specific protein binding sites in vivo.

This article has been cited by other articles:

• Kajiyama, Y., Tian, J., Locker, J. (2002). Regulation of {alpha}-Fetoprotein Expression by Nkx2.8. Mol. Cell. Biol. 22: 6122-6130 [Abstract] [Full Text]  
• Rausa, F. M., Tan, Y., Zhou, H., Yoo, K. W., Stolz, D. B., Watkins, S. C., Franks, R. R., Unterman, T. G., Costa, R. H. (2000). Elevated Levels of Hepatocyte Nuclear Factor 3beta in Mouse Hepatocytes Influence Expression of Genes Involved in Bile Acid and Glucose Homeostasis. Mol. Cell. Biol. 20: 8264-8282 [Abstract] [Full Text]  
• Gregori, C., Porteu, A., Lopez, S., Kahn, A., Pichard, A.-L. (1998). Characterization of the Aldolase B Intronic Enhancer. J. Biol. Chem. 273: 25237-25243 [Abstract] [Full Text]  
• Jin, D. K., Vacher, J., Feuerman, M. H. (1998). alpha -Fetoprotein gene sequences mediating Afr2 regulation during liver regeneration. Proc. Natl. Acad. Sci. USA 95: 8767-8772 [Abstract] [Full Text]  
• Sassi, H., Pictet, R., Grange, T. (1998). Glucocorticoids are insufficient for neonatal gene induction in the liver. Proc. Natl. Acad. Sci. USA 95: 5621-5625 [Abstract] [Full Text]  
• Nolten, L. A., Steenbergh, P. H., Sussenbach, J. S. (1996). The Hepatocyte Nuclear Factor 3beta Stimulates the Transcription of the Human Insulin-like Growth Factor I Gene in a Direct and Indirect Manner. J. Biol. Chem. 271: 31846-31854 [Abstract] [Full Text]  
• Vorachek, W. R., Steppan, C. M., Lima, M., Black, H., Bhattacharya, R., Wen, P., Kajiyama, Y., Locker, J. (2000). Distant Enhancers Stimulate the Albumin Promoter through Complex Proximal Binding Sites. J. Biol. Chem. 275: 29031-29041 [Abstract] [Full Text]